Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Yiming Wang
Institution:
Shanghai University of Traditional Chinese Medicine
Observed institution:
Shanghai University of Traditional Chinese Medicine
ORCID:
0009-0000-4687-3374
Observed ORCID:
0009-0000-4687-3374
OpenAlex ID:
A5138814727
Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
·
Cancer Research
·
4
Figure S8 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Supplemental Video S3 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Figure S9 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Figure S1 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Figure S3 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Figure S2 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Table S1 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Supplemental Video S4 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Figure S5 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Figure S10 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Table S6 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Supplemental Video S2 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Table S3 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Figure S7 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Figure S6 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Table S5 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Table S4 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Figure S4 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Table S2 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Supplemental Video S1 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Supplemental Video S5 from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Data from Base Editing of TIGIT Reprograms CD155 Signaling in Natural Killer Cells to Enhance Cancer Immunotherapy Efficacy
2026
·
Cheng Fang
, Guanglei Li
, et al.
Show more works
View as search
Works count:
23
Citation count:
4
H-index:
1
I10-index:
Year
Topic
Type